The Impact of Coronary Heart Disease Prevention on Work Productivity: A 10-Year Analysis

This ScienceDaily report covers an economic modeling study from Monash University, published in the European Journal of Preventive Cardiology, estimating the GDP benefit of preventing coronary heart disease in Australia over a 10-year horizon. The headline finding: full prevention of CHD across the study period could save approximately A$22 billion (USD $15 billion) in GDP through maintained workforce productivity, or roughly A$75,000 (USD $51,000) per case of CHD avoided.

The study introduces a novel framing — productivity-adjusted life years (PALYs) — that extends traditional QALY analysis to capture economic production losses. The largest contributor to productivity loss was early retirement (65.4%), followed by presenteeism (20.3%), absenteeism (8.4%), and premature death (5.9%). Men accounted for 62% of total productivity loss. A modest 10% prevention scenario still yielded approximately A$2 billion in GDP savings over the decade.

The policy implications are conventional but usefully quantified: the authors point to population-level interventions (trans fat bans, cycling infrastructure, sugar taxes, smoking bans) and workplace programs (exercise, healthy food) as the levers most likely to move the needle. The finding that 80% of CVD is potentially preventable through lifestyle modification contextualizes both the scale of opportunity and the distance between current practice and that ceiling.

The source is a news summary of peer-reviewed work, published in a major ESC journal. The economic modeling inherently relies on assumptions about disease progression and productivity — confidence intervals and sensitivity analyses are absent from the news report. The Australian data may not generalize directly to the US. These are standard limitations of modeled economic studies.

We rate the evidence moderate. This study provides a useful economic lens for evaluating cardiovascular prevention — reframing it as GDP investment rather than healthcare cost — with the caveats typical of economic modeling studies: assumption-dependent conclusions and geography-specific inputs.